ExCellThera

Private

MontrealHealthcare & Life Scienceshttps://excellthera.com/

Last Round

Grant

Sep 20, 2022

Total Funding Raised

$620,000

Company Overview

ExCellThera is a biotechnology company that develops and commercializes advanced cell expansion and engineering solutions for the treatment of blood cancers and other diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Data as a Service

AI Layer

Non-AI

Keywords

hematopoietic stem cellHSCcell expansioncell therapycord bloodstem cell therapyallogeneic transplantationex vivo expansioncell therapy manufacturingregenerative medicinesmall moleculehematological malignancybiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ExCellThera Comps

Public and private peers based on sector, stage, and business model.

ExCellThera comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ExCellThera Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Sep 20, 2022
Grant	Aug 7, 2020
Grant	Apr 5, 2017
Accelerator	Jun 15, 2015

View all Funding Rounds

Key People

Founding team and executive leadership

David Millette

Chief Executive Officer

Executive Team

Eric Martel

CFO

Executive Team

MSc Nathalie Bourgouin

Chief Operating Officer, VP, Quality and Compliance

Executive Team

ExCellThera Investors

Notable investors and investment history

ExCellThera investors
Investor	Rounds
IRICoR	Grant, Accelerator
CCRM	Accelerator
California Institute for Regenerative Medicine	Grant
Next Generation Manufacturing Canada (NGen)	Grant

View all Investors

ExCellThera Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ExCellThera Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ExCellThera's valuation, stock price, and market status.

Firmographic Details

HeadquartersMontreal

Employee Range16

Year Founded2014

Last FundingSep 20, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.